Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureSha Yu
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Targeting the notch signaling pathway and the notch ligand, DLL3, in small cell lung cancer
10.1016/j.biopha.2023.114248 · 2023
Efficacy and safety of anlotinib maintenance therapy in limited-stage small cell lung cancer
10.1007/s12672-025-03895-0 · 2025
Real-life clinical management patterns in extensive-stage small cell lung cancer across France: A multi-method study
10.1186/s12885-024-12117-9 · 2024
Comparison of atezolizumab, durvalumab, pembrolizumab, and nivolumab as first-line treatment in patients with extensive-stage small cell lung cancer: A systematic review and network meta-analysis
10.1097/md.0000000000025180 · 2021
HMGB1 promotes chemoresistance in small cell lung cancer by inducing PARP1-related nucleophagy
10.1016/j.jare.2023.12.020 · 2024
Small cell lung cancer: A review
10.1001/jama.2025.0560 · 2025
Clinicopathological features, risk and survival in lung cancer survivors with therapy-related acute myeloid leukaemia
10.3390/cancers12051081 · 2020
Diagnosis and treatment of therapy-related acute myeloid leukemia
10.1016/j.critrevonc.2022.103607 · 2022
Quality-adjusted time without symptoms of disease or toxicity (Q-TWiST) analysis of CPX-351 versus 7 + 3 in older adults with newly diagnosed high-risk/secondary AML
10.1186/s13045-021-01119-w · 2021
Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia
10.1016/j.cbi.2009.11.025 · 2010
Therapy-related myelodysplastic syndromes and acute myeloid leukemia
10.1053/j.seminhematol.2024.09.004 · 2024
Secondary neoplasm in survivors of childhood hematological malignancies-systematic review
2026
Very early onset of therapy-related acute myeloid leukemia with 11q23 rearrangement presenting with unusual PET findings after R-DA-EPOCH for primary mediastinal large B-cell lymphoma
10.3390/medicina58010048 · 2021
Introduction and interpretation of the updated contents of the International System for Human Cytogenomic Nomenclature
2021
A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer
10.1038/s41392-024-02115-5 · 2025
Therapy-related acute myeloid leukemia after chemotherapy in extensive disease-small cell lung cancer
10.1002/ccr3.1931 · 2019
ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer
10.1126/sciadv.ado4618 · 2024
Rare cytogenetic abnormalities and their clinical relevance in pediatric acute leukemia of Saudi Arabian population
10.1186/s13039-019-0454-0 · 2019
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia
10.1016/j.cancergencyto.2003.07.002 · 2004
Generation of the NUP98-TOP1 fusion transcript by the t(11;20) (p15;q11) in a case of acute monocytic leukemia
10.1016/s0165-4608(02)00642-8 · 2003
Both NUP98/TOP1 and TOP1/NUP98 transcripts are detected in a de novo AML with t(11;20)(p15;q11)
10.1002/gcc.10239 · 2003
HOXA9 transcription factor is a double-edged sword: From development to cancer progression
10.1007/s10555-023-10159-2 · 2024
The fusion partner specifies the oncogenic potential of NUP98 fusion proteins
10.1016/j.leukres.2013.09.013 · 2013
Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: Exploratory biomarker analysis of the randomized, phase 2 DESTINY-gastric01 trial
10.1038/s41591-024-02992-x · 2024
NUP98 fusion proteins interact with the NSL and MLL1 complexes to drive leukemogenesis
10.1016/j.ccell.2016.10.019 · 2016
Reversible switching of leukemic cells to a drug-resistant, stem-like subset via IL-4-mediated cross-talk with mesenchymal stroma
10.3324/haematol.2020.269944 · 2022
Recurrent translocations in topoisomerase inhibitor-related leukemia are determined by the features of DNA breaks rather than by the proximity of the translocating genes
10.3390/ijms23179824 · 2022
Progress toward better treatment of therapy-related AML
10.3390/cancers15061658 · 2023
Tumor activated cell penetrating peptides to selectively deliver immune modulatory drugs
10.3390/pharmaceutics13030365 · 2021
DNA damage, DNA repair and carcinogenicity: Tobacco smoke versus electronic cigarette aerosol
10.1016/j.mrrev.2021.108409 · 2022
The relation between cigarette smoking and risk of acute myeloid leukemia: An updated meta-analysis of epidemiological studies
10.1002/ajh.23744 · 2014
Cigarette smoke exposure accelerates AML progression in FLT3-ITD models
10.1182/bloodadvances.2023010111 · 2023
No additional external references are available.